{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0000", "char_start": 0, "char_end": 1200, "pages": [1], "text": "December 2020\nVolume 36 | Number 17\nMedicaid Pharmacy Carve-Out\nSpecial Edition – Part One\nThis publication provides information regarding the Medicaid Pharmacy Carve-Out, a Medicaid Redesign\nTeam (MRT) II initiative to transition the pharmacy benefit from managed care to the Medicaid Fee-for-Service\n(FFS) Pharmacy Program. It contains general information regarding New York State’s (NYS) transition\nstrategy and other important facts that will assist providers in transitioning members to the FFS Pharmacy\nProgram. Future Medicaid Update articles will provide additional details and guidance. More detailed\ninformation is available and regularly updated on the Pharmacy Carve-Out web page.\nGeneral Information\nEffective April 1, 2021, Medicaid members enrolled in mainstream Managed Care (MC) plans, Health and\nRecovery Plans (HARPs), and HIV-Special Needs Plan (SNPs) will receive their pharmacy benefits through\nthe Medicaid FFS Pharmacy Program instead of through their Medicaid MC plan as they do now. The\nPharmacy Carve-Out does not apply to members enrolled in Managed Long-Term Care plans (e.g., MLTC,\nPACE and MAP), the Essential Plan, or Child Health Plus (CHP). Transitioning the pharmac"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0001", "char_start": 1050, "char_end": 2250, "pages": [1], "text": "members enrolled in Managed Long-Term Care plans (e.g., MLTC,\nPACE and MAP), the Essential Plan, or Child Health Plus (CHP). Transitioning the pharmacy benefit from\nMC to FFS will provide the State with full visibility into prescription drug costs, allow centralization of the\nbenefit, leverage negotiation power, and provide a single drug formulary with standardized utilization\nmanagement protocols simplifying and streamlining the drug benefit for Medicaid members.\nScope of Benefits\nThe FFS Pharmacy Carve-Out will not change the scope (e.g. copayments, covered drugs, etc.) of the\nexisting Medicaid Pharmacy benefit, which includes:\n• Covered outpatient prescription and over-the-counter (OTC) drugs that are listed on the Medicaid\nPharmacy List of Reimbursable Drugs;\n• Pharmacist administered vaccines and supplies listed in the Pharmacy Procedures and Supply Codes\ndocument, such as enteral and parenteral nutrition, family planning, and medical/surgical supplies.\nThe complete list of items subject to the Pharmacy Benefit Carve-Out can be reviewed in the Carve-Out\nScope web page. Please Note: Physician administered (J-Code) drugs that are not listed on the Medicaid\nPharmacy List of Reimb"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0002", "char_start": 2100, "char_end": 3300, "pages": [1, 2], "text": "eviewed in the Carve-Out\nScope web page. Please Note: Physician administered (J-Code) drugs that are not listed on the Medicaid\nPharmacy List of Reimbursable Drugs and durable medical equipment, prosthetics, orthotics, and supplies\n(DMEPOS) as listed in sections 4.4, 4.5, 4.6, and 4.7 of the Durable Medical Equipment, Prosthetics and\nSupplies Manual are not subject to the carve-out. These items will remain the responsibility of the MC Plans.\nContinued on Page 3\n\nAndrew M. Cuomo\nGovernor\nState of New York\nHoward A. Zucker, M.D., J.D.\nCommissioner\nNew York State\nDepartment of Health\nDonna Frescatore\nMedicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nMedicaid Pharmacy Carve-Out ................................................................................................................ Cover\nGeneral Information.......................................................................................................................................1\nScope of Benefits....................................................................................................................."}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0003", "char_start": 3150, "char_end": 4350, "pages": [2], "text": "..............1\nScope of Benefits..........................................................................................................................................1\nTransition Strategy ........................................................................................................................................3\nInformation for Pharmacies.............................................................................................................................4\nInformation for Prescribers .............................................................................................................................5\nInformation for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Providers .....................5\nReferences and Links ....................................................................................................................................6\nAdditonal Resources .....................................................................................................................................6\nProvider Directory .............................................................................................................."}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0004", "char_start": 4200, "char_end": 5400, "pages": [2, 3], "text": "...................6\nProvider Directory .........................................................................................................................................7\nSpecial Edition – Part One: Pharmacy Carve-Out New York State Medicaid Update pg. 2\n\nEffective April 1, 2021, the following Medicaid Pharmacy FFS Programs will also apply to Medicaid managed\ncare members:\n• Preferred Drug Program (PDP)\nThis program promotes the use of less expensive, equally effective prescription drugs when medically\nappropriate. All drugs currently covered by Medicaid remain available under the PDP and the\ndetermination of preferred and non-preferred drugs does not prohibit a prescriber from obtaining any\nof the medications covered under Medicaid. The Drug Utilization Review Board (DURB) reviews drug\nclasses and makes recommendations to the Commissioner of Health regarding the selection of\npreferred and non-preferred drugs within certain drug classes.\n• Brand Less Than Generic Program (BLTG)\nThis program is a cost containment initiative which promotes the use of certain multi-source brand\nname drugs when the cost of the brand name drug is less expensive to the State, than the generic\nequ"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0005", "char_start": 5250, "char_end": 6450, "pages": [3], "text": "ch promotes the use of certain multi-source brand\nname drugs when the cost of the brand name drug is less expensive to the State, than the generic\nequivalent.\n• Clinical Drug Review Program (CDRP)\nThis program is aimed at ensuring specific drugs are utilized in a medically appropriate manner. Under\nthe CDRP, certain drugs require prior authorization because there may be specific safety issues,\npublic health concerns, the potential for fraud and abuse or the potential for significant overuse and\nmisuse.\n• Drug Utilization Review (DUR) Program\nThis program helps to ensure that prescriptions for outpatient drugs are appropriate, medically\nnecessary, and not likely to result in adverse medical consequences. DUR programs use professional\nmedical protocols and computer technology and data processing to assist in the management of data\nregarding the prescribing of medicines and the dispensing of prescriptions over periods of time.\n• Mandatory Generic Drug Program (MGDP)\nThis program requires prior authorization for brand-name prescriptions with an A-rated generic\nequivalent. State law excludes Medicaid coverage of brand name drugs that have a Federal Food and\nDrug Administration (FDA) app"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0006", "char_start": 6300, "char_end": 7500, "pages": [3, 4], "text": "ith an A-rated generic\nequivalent. State law excludes Medicaid coverage of brand name drugs that have a Federal Food and\nDrug Administration (FDA) approved A-rated generic equivalent, unless a prior authorization is\nobtained. Drugs subject to the PDP and/or the BLTG Program are not subject to the Mandatory\nGeneric Program.\n• Dose Optimization Program\nThis program can reduce prescription costs by reducing the number of pills a patient needs to take\neach day. The Department has identified the drugs that are included in this program, the majority of\nwhich have FDA approval for once-a-day dosing, have multiple strengths available in correlating\nincrements at similar costs and are currently being utilized above the recommended dosing frequency.\n• Preferred Diabetic Supply Program (PDSP)\nThe NYS Medicaid Program participates in a Preferred Diabetic Supply Program (PDSP) to provide\nNYS Medicaid enrollees access to quality glucose meters and test strips, while at the same time\nreducing overall program costs.\nSpecial Edition – Part One: Pharmacy Carve-Out New York State Medicaid Update pg. 3\n\nTransition Strategy:\n• Stakeholder Engagement: The NYS Department of Health (the Department) has be"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0007", "char_start": 7350, "char_end": 8550, "pages": [3, 4], "text": "cy Carve-Out New York State Medicaid Update pg. 3\n\nTransition Strategy:\n• Stakeholder Engagement: The NYS Department of Health (the Department) has been conducting\nmonthly meetings with all interested stakeholders since July 2020. The purpose of the meetings is to\nprovide implementation updates, facilitate a Q&A session, and to incorporate feedback received from\nsessions into the workplan.\n• Data Analytics: The Department is analyzing managed care claims by program area to inform\ntransition strategy. Slides 12 and 13 of the October 19, 2020 All Stakeholder presentation provide\ndetails regarding this analysis and the transition strategy that will be used to ensure continued access\nto medications.\n• Transition Period: Between April 1, 2021 and June 30, 2021, members will be able to obtain a one-\ntime fill for medications that are non-preferred in FFS without the normal prior authorization\nrequirement. This will allow additional time for prescribers to switch members to an FFS preferred\nmedication (no prior authorization required) or obtain a prior authorization for the non-preferred\nmedication.\n• Prior Authorization (PA):\nPAs for drugs previously authorized by MC plans will be recogn"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0008", "char_start": 8400, "char_end": 9600, "pages": [4], "text": "ain a prior authorization for the non-preferred\nmedication.\n• Prior Authorization (PA):\nPAs for drugs previously authorized by MC plans will be recognized/honored by the FFS\nprogram following the Carve-Out. The MC plans will share with the Department the PAs that\nhave been previously approved.\nNo PA will be required when FFS PA requirements (e.g. correct diagnosis) are met, according\nto the member’s managed care claims history.\n• Communication: Communication about the transition of the pharmacy benefit to FFS will be made\nby both the Department and the MC Plans and will be accomplished through a variety of methods\nincluding general and targeted communications and Medicaid Update articles. Additional information\nregarding these communications and their timing can be found within the Transition and\nCommunications Activities Timeline document.\nInformation for Pharmacies\nEnrollment\nPlease refer to the October 2020 Medicaid Update article titled Attention: Pharmacies Durable Medical\nEquipment, Prosthetics, Orthotics, and Supply Providers, and Prescribers That are Not Enrolled in Medicaid\nFee-for-Service. Pharmacies that are not enrolled in the FFS program as billing providers must enrol"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0009", "char_start": 9450, "char_end": 10650, "pages": [4], "text": "and Prescribers That are Not Enrolled in Medicaid\nFee-for-Service. Pharmacies that are not enrolled in the FFS program as billing providers must enroll, in order\nto continue to serve Medicaid Managed Care members. Instructions for checking enrollment status, and\nenrollment tips can be found in this article.\nBilling Changes\n• Member Identification Number: Beginning April 1, 2021. Pharmacies will bill the Medicaid FFS\nProgram using the Client Identification Number (CIN), which can be found on both the FFS Client\nBenefit Identification Card (CBIC) or the member’s MC plan card.\nThe Client Identification Number or CIN is a unique number assigned to each Medicaid\nmembers. This number is used by the pharmacy to submit pharmacy claims to Medicaid FFS.\nAll Medicaid members are assigned a CIN even if they are enrolled in a Medicaid managed\ncare (MMC) plan. The CIN is located on all member cards including MMC plan cards. On some\nMMC cards it is referred to as CIN, however other MMC cards may identify it as Program ID,\nMember ID, or ID#. While in some cases it may be embedded into a longer number the CIN is\nalways represented in this format: “AA11111A”.\nFor assistance locating the CIN on an MM"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0010", "char_start": 10500, "char_end": 11700, "pages": [4, 5], "text": " some cases it may be embedded into a longer number the CIN is\nalways represented in this format: “AA11111A”.\nFor assistance locating the CIN on an MMC plan card, please visit the NYS Pharmacy Benefit\nInformation Center website. From the Homepage, providers can select a plan to display an\nimage of the plan card and where the CIN is located.\n• Bank Identification Number (BIN) and Processor Control Number (PCN): For submitting FFS\nclaims to Medicaid via NCPDP D.0, the BIN number is required in field 101-A1 and is “004740”. The\nPCN (Processor Control Number) is required to be submitted in field 104-A4. The PCN has two\nformats, which are comprised of 10 characters:\nSpecial Edition – Part One: Pharmacy Carve-Out New York State Medicaid Update pg. 4\n\nFirst format for 3-digit Electronic Transaction Identification Number (ETIN):\n\"Y\"- (Yes, read Certification statement) -(1)\nPharmacists Initials- (2)\nProvider PIN Number- (4)\n3-digit ETIN- (Electronic Transaction Identification Number)- (3)\nSecond format for 4-digit ETIN:\nPharmacist Initials- (2)\nProvider PIN Number- (4)\n4-digit ETIN- (Electronic Transaction Identification Number)- (4)\nEligibility Determination\nInformation regarding methods "}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0011", "char_start": 11550, "char_end": 12750, "pages": [5], "text": "2)\nProvider PIN Number- (4)\n4-digit ETIN- (Electronic Transaction Identification Number)- (4)\nEligibility Determination\nInformation regarding methods to determine a Medicaid member’s eligibility will be included in a subsequent\nMedicaid Update article.\nInformation for Prescribers\nEnrollment\nPlease refer to the October 2020 Medicaid Update article titled Attention: Pharmacies Durable Medical\nEquipment, Prosthetics, Orthotics, and Supply Providers, and Prescribers That are Not Enrolled in Medicaid\nFee-for-Service. Prescribers that are not enrolled in the FFS program must enroll, in order to continue to serve\nMedicaid Managed Care. Instructions for checking enrollment status, and enrollment tips can be found in this\narticle.\nPrior Authorization\nPrescribers should review the Preferred Drug List (PDL), which contains a full listing of drugs/classes subject\nto the NYS State Medicaid FFS Pharmacy Programs and additional information on clinical criteria prior to\nApril 1, 2021. Prescribers may either switch members to a preferred product or may obtain a PA for a non-\npreferred product. See below for instructions on requesting a PA or refer to the PDP web page.\n• To initiate the PA process, "}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0012", "char_start": 12600, "char_end": 13800, "pages": [5], "text": "y obtain a PA for a non-\npreferred product. See below for instructions on requesting a PA or refer to the PDP web page.\n• To initiate the PA process, the prescriber must call the PA call center at (877) 309-9493 and select\noption \"1\" for prescriber. The call center is operational 24 hours a day, seven days per week.\n• Fax requests are permitted for most drugs. Completed PA forms should be sent to (800) 268-2990.\nFax requests may take up to 24 hours to process. PA forms and references are available on the\nwebpage.\n• Billing questions should be directed to (800) 343-9000.\n• Clinical concerns or PDP questions should be directed to (877) 309-9493 or visit the NYS Medicaid\nPharmacy Programs page.\n• Medicaid pharmacy policy and operations questions should be directed to (518) 486-3209.\nInformation for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Providers\nEnrollment\nPlease refer to the October 2020 Medicaid Update article titled Attention: Pharmacies Durable Medical\nEquipment, Prosthetics, Orthotics, and Supply Providers, and Prescribers That are Not Enrolled in Medicaid\nFee-for-Service. DMEPOS providers that are not enrolled in the FFS program must enroll as "}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0013", "char_start": 13650, "char_end": 14850, "pages": [5, 6], "text": "roviders, and Prescribers That are Not Enrolled in Medicaid\nFee-for-Service. DMEPOS providers that are not enrolled in the FFS program must enroll as billing providers\nin order to continue to serve Medicaid Managed Care. Instructions for checking enrollment status, and\nenrollment tips can be found in this article.\nSupplies\nSupplies listed in the Pharmacy Procedures and Supply Codes, such as enteral and parenteral nutrition,\nfamily planning and medical/surgical supplies are subject to the Pharmacy Carve-Out. Items that will remain\nthe responsibility of the MC plans include durable medical equipment, prosthetics, orthotics, and supplies\n(DMEPOS) as listed in Sections 4.4, 4.5, 4.6, and 4.7 of the Durable Medical Equipment, Prosthetics and\nSupplies Manual and are not subject to the carve-out.\nSpecial Edition – Part One: Pharmacy Carve-Out New York State Medicaid Update pg. 5\n\nReferences and Links:\n• Pharmacy Carve-Out and Frequently Asked Questions (FAQs)\n• Medicaid Pharmacy Program\n• Pharmacy Manual\n• Outpatient Prescription Drugs: Medicaid Pharmacy List of Reimbursable Drugs\n• Supplies Covered Under the Pharmacy Benefit\n• Medicaid Preferred Diabetic Supply Program\n• FFS Preferred Dr"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0014", "char_start": 14700, "char_end": 15900, "pages": [6, 7], "text": "caid Pharmacy List of Reimbursable Drugs\n• Supplies Covered Under the Pharmacy Benefit\n• Medicaid Preferred Diabetic Supply Program\n• FFS Preferred Drug List\n• Drug Utilization Review Board (DURB)\n• NYS Medicaid Program Pharmacists As Immunizers Fact Sheet\n• Member Rights\nAdditional Resources:\n• All questions regarding the Pharmacy Carve-Out should be emailed to PPNO@health.ny.gov. Please\ninclude “Carve-Out” in the subject line.\n• Providers interested in receiving MRT email alerts, visit the MRT LISTSERV web page to subscribe.\n****************************************************************************************************************\nSpecial Edition – Part One: Pharmacy Carve-Out New York State Medicaid Update pg. 6\n\nProvider Directory\nOffice of the Medicaid Inspector General:\nFor suspected fraud or abuse complaints/allegations, call 1-877-87FRAUD, (877) 873-7283, or visit Office of\nMedicaid Inspector General (OMIG) web site.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0015", "char_start": 15750, "char_end": 16950, "pages": [7], "text": "Y website.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor questions about billing and performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nPlease enroll online for a provider seminar. For individual training requests, call (800) 343-9000.\nBeneficiary Eligibility:\nCall the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current information on best practices in pharmacotherapy, please visit the following websites:\n• DOH Prescriber Education Program page\n• Prescriber Education Program in partnership with SUNY\neMedNY\nFor a number of services, including: change of address, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment, please visit eMedNY’s Provider\nEnrollment page and choose the appropriate link based on provider type.\nNY Medicaid Electronic Health Record (EHR) Incentive Program\nContact the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding Th"}
{"doc_id": "mu_no17_dec20_speced_pr.pdf", "chunk_id": "mu_no17_dec20_speced_pr.pdf::0016", "char_start": 16800, "char_end": 17122, "pages": [7], "text": "h Record (EHR) Incentive Program\nContact the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Angela Lince, at medicaidupdate@health.ny.gov.\nSpecial Edition – Part One: Pharmacy Carve-Out New York State Medicaid Update pg. 7"}
